Skip to search formSkip to main contentSkip to account menu

6'-di-N-methylfortimicin A

Known as: 6'-DN-MFA, L-chiro-Inositol, 4-amino-1-((aminoacetyl)methylamino)-3-O-(2-amino-2,3,4,6,7-pentadeoxy-6-(dimethylamino)-beta-L-lyxo-heptopyranosyl)-1,4-dideoxy-6-O-methyl- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
  • Y. UnoH. Yamazaki
  • 2020
  • Corpus ID: 207892161
Abstract 1. Although the cynomolgus macaque is an important non-human primate species used in drug metabolism studies, cynomolgus… 
2015
2015
Abstract The effect of mechanical impact on the polymorphic transformation of mefenamic acid (MFA) and the formation of a solid… 
2011
2011
Three dimensional quantitative structure-activity relationship (3D-QSAR) studies have been performed on a series of 2… 
2010
2010
aiming at the disadvantages of high computation overhead and bad extensibility in matrix weighted fusion method, a multi-sensor… 
2006
2006
properties, including chip density, fibre length, glucose content, fibre coarseness and microfibril angle. Models were developed… 
2006
2006
The preparation of 4-de-N-methylfortimicin A analogs as well as the preparation of 4-deN-methyl-4-N-(1S-aminoethyl)-4-N… 
1993
1993
Application of multifraction absorption models to pharmacokinetic analysis of an oral sustained-release diltiazem preparation… 
1981
1981
The preparation of 4-de-N-methylfortimicin A analogs as well as the preparation of 4-de-N-methyl-4-N-(beta-aminoethyl)-4-N… 
1981
1981
Selective 6'-N-alkylation of 1,2'-di-N-benzyloxycarbonylfortimicin B was effected by both catalytic and chemical reductive…